Search for Clinical Trial Results
Mucopolysaccharidosis Type IV - 47 Studies Found
Status | Study |
Enrolling by invitation |
Study Name: Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox Condition: Cartilage-hair Hypoplasia Date: 2015-02-10 Interventions: Biological: Varilrix Vaccination against varicella in selected cartilage-hair hypoplasia patients |
Enrolling by invitation |
Study Name: BMN 110 Phase 3B in Australian Patients Condition: Mucopolysaccharidosis IVA (Morquio A Syndrome) Date: 2013-09-10 Interventions: Drug: BMN 110 All pateints receive treatment with BMN 110 |
Terminated |
Study Name: Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation Condition:
Date: 2012-09-17 Interventions: Drug: BMN 110 Drug will be delivered through a 4 hour (approximate) IV infusion at a dosage amount of 2. |
Terminated |
Study Name: Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome Condition:
Date: 2012-05-24 Interventions: |
Completed |
Study Name: Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition:
Date: 2011-12-22 Interventions: Drug: BMN 110 Patients will receive intravenous (IV) infusions of study drug at a dose of 2.0 mg/kg/wk o |
Terminated |
Study Name: Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA Condition: Mucopolysaccharidosis Type IVA Date: 2012-11-21 |
Active, not recruiting |
Study Name: Psychological Concomitants of Morquio A Syndrome - Longitudinal Effects of Enzyme Replacement Therapy (The MAPLE Study) Condition:
|
Active, not recruiting |
Study Name: Gait Analysis in MPS IVA Condition:
|
Completed |
Study Name: A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: MPS IV A Date: 2011-01-10 Interventions:
|
Completed |
Study Name: Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition:
|